Mississippi HB 1667: Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.

Status: Died In Committee (as of 2026-02-03)

State: Mississippi · Session: 2026 · Bill: HB 1667

Subjects: State Affairs

Sponsors: Tullos

View Mississippi HB 1667 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.